112 related articles for article (PubMed ID: 30611057)
1. Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Velnati S; Ruffo E; Massarotti A; Talmon M; Varma KSS; Gesu A; Fresu LG; Snow AL; Bertoni A; Capello D; Tron GC; Graziani A; Baldanzi G
Eur J Med Chem; 2019 Feb; 164():378-390. PubMed ID: 30611057
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.
Ruffo E; Malacarne V; Larsen SE; Das R; Patrussi L; Wülfing C; Biskup C; Kapnick SM; Verbist K; Tedrick P; Schwartzberg PL; Baldari CT; Rubio I; Nichols KE; Snow AL; Baldanzi G; Graziani A
Sci Transl Med; 2016 Jan; 8(321):321ra7. PubMed ID: 26764158
[TBL] [Abstract][Full Text] [Related]
3. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.
Boroda S; Niccum M; Raje V; Purow BW; Harris TE
Biochem Pharmacol; 2017 Jan; 123():29-39. PubMed ID: 27974147
[TBL] [Abstract][Full Text] [Related]
4. Identification of ritanserin analogs that display DGK isoform specificity.
Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
[TBL] [Abstract][Full Text] [Related]
5. Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction.
Velnati S; Centonze S; Rossino G; Purghè B; Antona A; Racca L; Mula S; Ruffo E; Malacarne V; Malerba M; Manfredi M; Graziani A; Baldanzi G
Front Immunol; 2023; 14():1043603. PubMed ID: 37138877
[TBL] [Abstract][Full Text] [Related]
6. Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method.
Sato M; Liu K; Sasaki S; Kunii N; Sakai H; Mizuno H; Saga H; Sakane F
Pharmacology; 2013; 92(1-2):99-107. PubMed ID: 23949095
[TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
Dominguez CL; Floyd DH; Xiao A; Mullins GR; Kefas BA; Xin W; Yacur MN; Abounader R; Lee JK; Wilson GM; Harris TE; Purow BW
Cancer Discov; 2013 Jul; 3(7):782-97. PubMed ID: 23558954
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.
Velnati S; Centonze S; Girivetto F; Baldanzi G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072296
[TBL] [Abstract][Full Text] [Related]
9. Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics.
McCloud RL; Franks CE; Campbell ST; Purow BW; Harris TE; Hsu KL
Biochemistry; 2018 Jan; 57(2):231-236. PubMed ID: 29155586
[TBL] [Abstract][Full Text] [Related]
10. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
[TBL] [Abstract][Full Text] [Related]
11. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
Olmez I; Love S; Xiao A; Manigat L; Randolph P; McKenna BD; Neal BP; Boroda S; Li M; Brenneman B; Abounader R; Floyd D; Lee J; Nakano I; Godlewski J; Bronisz A; Sulman EP; Mayo M; Gioeli D; Weber M; Harris TE; Purow B
Neuro Oncol; 2018 Jan; 20(2):192-202. PubMed ID: 29048560
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
Jiang Y; Sakane F; Kanoh H; Walsh JP
Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
[TBL] [Abstract][Full Text] [Related]
13. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells.
Du X; Jiang Y; Qian W; Lu X; Walsh JP
Biochem J; 2001 Jul; 357(Pt 1):275-82. PubMed ID: 11415460
[TBL] [Abstract][Full Text] [Related]
14. Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.
Hayashi D; Tsumagari R; Liu K; Ueda S; Yamanoue M; Sakane F; Shirai Y
J Biochem; 2019 Jun; 165(6):517-522. PubMed ID: 30715374
[TBL] [Abstract][Full Text] [Related]
15. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus mutans diacylglycerol kinase homologue: a potential target for anti-caries chemotherapy.
Shibata Y; Kawada-Matsuo M; Shirai Y; Saito N; Li D; Yamashita Y
J Med Microbiol; 2011 May; 60(Pt 5):625-630. PubMed ID: 21317193
[TBL] [Abstract][Full Text] [Related]
17. Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors.
Velnati S; Massarotti A; Antona A; Talmon M; Fresu LG; Galetto AS; Capello D; Bertoni A; Mercalli V; Graziani A; Tron GC; Baldanzi G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):96-108. PubMed ID: 31690133
[TBL] [Abstract][Full Text] [Related]
18. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.
Meinhardt G; Eppinger E; Schmidmaier R
Anticancer Drugs; 2002 Aug; 13(7):725-33. PubMed ID: 12187329
[TBL] [Abstract][Full Text] [Related]
19. Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.
Torres-Ayuso P; Daza-Martín M; Martín-Pérez J; Ávila-Flores A; Mérida I
Oncotarget; 2014 Oct; 5(20):9710-26. PubMed ID: 25339152
[TBL] [Abstract][Full Text] [Related]
20. A diacylglycerol kinase inhibitor, R59022, stimulates glucose transport through a MKK3/6-p38 signaling pathway in skeletal muscle cells.
Takahashi N; Nagamine M; Tanno S; Motomura W; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2007 Aug; 360(1):244-50. PubMed ID: 17588539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
